MOBILE VIEW  | 

HYPOCHLORITES AND RELATED AGENTS

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Sodium hypochlorite is used as a bleaching agent for pulps, fibers, and paper, as a household bleach, for water purification, as a fungicide, in certain pharmaceutical preparations, and as a chemical intermediate. The pentahydrate solution is prepared from the combination of sodium hydroxide and chloride in the presence of water.
    B) Calcium hypochlorite is used as a bleaching or oxidizing agent, as an algicide or fungicide, as a deodorant or disinfectant, and in sugar refining. Commercial preparations usually contain 50% or more calcium hypochlorite, although the pure product has not been prepared.

Specific Substances

    A) SODIUM HYPOCHLORITE
    1) Bleach
    2) Carrel-Dakin solution
    3) Chlorox
    4) Clorox
    5) Dakins solution
    6) Eau de Javel
    7) Javex
    8) Modified Dakins solution
    9) Sodium hypochlorite, pentahydrate
    10) Surgical chlorinated soda solution
    11) CAS 7681-52-9
    CALCIUM HYPOCHLORITE
    1) Bleaching powder
    2) Calcium chlorohydrochlorite
    3) Calcium hypochloride
    4) Calcium oxychloride
    5) Chloride of lime
    6) Chlorinated lime
    7) HTH
    8) HTH dry chlorine
    9) Hy-chlor
    10) Hypochlorous acid, calcium salt
    11) Lime chloride
    12) Losantin
    13) Natural anhydrous calcium hypochlorite
    14) Sentry
    15) CAS 7778-54-3
    GENERAL TERMS
    1) Hypochlorite solution
    2) Hipoclorito calcico (spanish)
    3) Chlorine active compounds
    4) Calcium hypochlorite mixture, dry
    5) Calcium chlorohypochloride

Available Forms Sources

    A) USES
    1) Sodium hypochlorite is used as a bleaching agent for pulps, fibers, and paper, as a household bleach, for water purification, as a fungicide, in certain pharmaceutical preparations, and as a chemical intermediate (ITI, 1985). The pentahydrate solution is prepared from the combination of sodium hydroxide and chloride in the presence of water (Windholz et al, 1983).
    2) Calcium hypochlorite is used as a bleaching or oxidizing agent, as an algicide or fungicide, as a deodorant or disinfectant, and in sugar refining (ITI, 1985; Windholz et al, 1983). Commercial preparations usually contain 50% or more calcium hypochlorite, although the pure product has not been prepared (Windholz et al, 1983).
    3) Sodium hypochlorite is usually found in a 5.4% solution as household bleach for use in washing machines and other clean-up procedures.
    4) Chloramine has been used as a wound antiseptic in dilute concentration and is non-toxic and not absorbed if contact is less than 2 to 3 hours.
    5) Chloramine is a common agent used to purify public water supplies. It presents a potential hazard to home dialysis patients.

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) USES: Hypochlorite is an aqueous solution produced via the reaction of chlorine gas with water. Most household bleach solutions contain 3% to 5% hypochlorite, while swimming pool disinfectants and industrial strength cleaners may contain up to 20% hypochlorite. Addition of an acid to a hypochlorite solution may release chlorine gas, while the ammonia may react with hypochlorite solutions to release chloramine, a gas with properties similar to chlorine. This scenario most often develops when several different household cleaning products are mixed.
    B) TOXICOLOGY: Dilute aqueous hypochlorite solutions (3% to 5%) may be moderately irritating to the skin but rarely cause serious burns, unless very large volumes are ingested. More concentrated industrial cleaners (20% hypochlorite) may cause more serious corrosive injuries. Both chlorine and chloramine gas are pulmonary irritants and produce a corrosive effect on contact with moist tissues (eg, eyes, upper respiratory tract). Chloramine is less water soluble than chlorine and may produce more delayed effects.
    C) EPIDEMIOLOGY: There are thousands of annual exposures in the United States to hypochlorite solutions, but only a small percentage seeks medical attention, and outcomes are rarely serious.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE POISONING: Ingestion of dilute (3% to 5%) aqueous hypochlorite solutions will cause immediate burning in the mouth and throat, but no further injury would be expected.
    2) SEVERE POISONING: Ingestions of more concentrated solutions may cause significant esophageal and gastric burns, and patients may manifest dysphagia, drooling, and severe throat, chest, and abdominal pain. Hematemesis and gastrointestinal perforations can occur.
    3) INHALATION: Most common respiratory symptoms included cough, upper respiratory irritation, and dyspnea. Reaction of an acid with a hypochlorite solution liberates chlorine gas, which has relatively high water solubility. This leads to an irritant effect on the mucous membranes (eg, eyes, nose, and throat) of those nearby and may trigger wheezing and other respiratory symptoms, particularly in those with preexisting diseases such as asthma or COPD. In serious exposures, which are rare with household products, upper airway edema may cause obstruction, and lethal noncardiogenic pulmonary edema (chemical pneumonitis) may also occur.
    4) INTRAVENOUS: Acute renal injury, intravascular hemolysis, and mild myocardial injury developed after parenteral self-administration of a large quantity of sodium hypochlorite.
    5) OCULAR OR DERMAL: Ocular or dermal exposures to chlorine gas or hypochlorite solutions can cause irritation and corrosive injuries.

Laboratory Monitoring

    A) Obtain a chest radiograph and monitor pulse oximetry and arterial blood gases in patients with respiratory signs or symptoms. Further imaging studies may be required for patients with a history of a large or high concentration ingestion, especially if there is concern for perforation (eg, x-rays, endoscopy, esophagram).
    B) Monitor electrolytes in patients with large ingestions of sodium hypochlorite.

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) Supportive care and removal from exposure or decontamination are the mainstays of treatment. Remove contaminated clothing and copiously irrigate exposed eyes or skin with water or saline. Patients with respiratory exposures should leave the area of exposure immediately and receive supplemental oxygen, bronchodilators, and advanced airway support (eg, intubation) as necessary. Nebulized sodium bicarbonate (3.75%) has been used to treat respiratory irritation after chlorine inhalation in some cases and is suggested by some experts. Dilute with small amounts of milk or water following an ingestion.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Standard burn care should be applied for serious ocular and dermal corrosive effects. Severe respiratory distress requires intubation. For ingestions of hypochlorite solutions greater than 10% or symptoms of severe corrosive injuries (ie, dysphagia, drooling, pain), flexible endoscopy should be performed to evaluate the extent of esophageal or gastric injury. Chest and abdominal x-rays may be useful to look for mediastinal or intraabdominal free air secondary to perforations in the gastrointestinal tract, which require surgical intervention.
    C) DECONTAMINATION
    1) PREHOSPITAL: For ingestions, dilute with small amounts of milk or water. Activated charcoal is CONTRAINDICATED. Remove contaminated clothing, wash exposed skin, and irrigate exposed eyes with normal saline or water following dermal exposure.
    2) HOSPITAL: Gastric aspiration could be helpful for large and relatively recent ingestions of high concentration hypochlorite solutions, but this entails the potential risk of damage to a burned esophagus. Remove contaminated clothing, wash skin, and irrigate exposed eyes until ocular pH is normal.
    D) AIRWAY MANAGEMENT
    1) For respiratory exposures to chlorine and chloramine gas, severe exposures may require intubation, especially for those showing signs of airway edema or obstruction (ie, croupy cough, hoarseness, stridor) or those in severe respiratory distress secondary to pulmonary edema.
    E) ANTIDOTE
    1) None.
    F) ENHANCED ELIMINATION
    1) There is no role for enhanced elimination.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Patients with minimal inadvertent exposures who remain asymptomatic or develop mild symptoms with resolution may remain at home.
    2) OBSERVATION CRITERIA: All patients with persistent symptoms or intentional exposures should be sent to a health care facility for observation for the longer of 4 to 6 hours or until symptoms resolve. Criteria for discharge should include symptom resolution.
    3) ADMISSION CRITERIA: Patients with persistent symptoms after a period of observation and supportive treatment should be admitted to the hospital. Depending on the severity of the symptoms (eg, intubation for pulmonary edema), an ICU bed may be needed. Criteria for hospital discharge should be improvement or resolution of symptoms.
    4) CONSULT CRITERIA: Depending on the route of exposure and symptoms, it may be appropriate to consult a burn specialist, gastroenterologist, ophthalmologist, or intensivist. For large-scale exposures, public health and hazardous materials personnel should be notified. A poison center, medical toxicologist, or both should be contacted for moderate to severe exposures.
    H) PITFALLS
    1) For ingestions, lack of significant initial damage in the oropharynx does not mean deeper, significant gastrointestinal injury cannot develop. Physical exertion can exacerbate symptoms during an ongoing respiratory exposure, as the total exposure will increase with increased minute ventilation.
    I) TOXICOKINETICS
    1) Most patients will have at least mild symptoms immediately.
    J) PREDISPOSING CONDITIONS
    1) Patients with bronchospastic disease may be more sensitive to respiratory exposures, especially children, since they have smaller airways than adults.
    K) DIFFERENTIAL DIAGNOSIS
    1) The differential diagnosis can include contamination by other caustic substances or exposure to other irritant gases. Other nontoxic etiologies can cause similar symptoms (ie, burns, respiratory distress).
    0.4.3) INHALATION EXPOSURE
    A) Remove from exposure, administer oxygen, bronchodilators for wheezing or persistent cough. Nebulized sodium bicarbonate (3.75%) has been used to treat respiratory irritation after chlorine inhalation in some cases and is suggested by some experts. Intubation should be performed early in patients with evidence of upper airway edema (eg, stridor, severe respiratory distress).
    B) ACUTE LUNG INJURY: Maintain ventilation and oxygenation and evaluate with frequent arterial blood gases and/or pulse oximetry monitoring. Early use of PEEP and mechanical ventilation may be needed.
    0.4.4) EYE EXPOSURE
    A) Immediate copious eye irrigation until pH is neutral. Slit lamp exam, with emergent referral to an ophthalmologist if there is any evidence of ocular burns.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) REMOVE ALL EXPOSED CLOTHING AND WASH EXPOSED AREAS of the body twice with water. Standard burn care (eg, dressings, antibiotic ointment) for corrosive injuries. Wash all exposed clothes with soap and water. Complications are unlikely. A physician may need to examine the exposed area if pain or irritation persists after the area is washed.

Range Of Toxicity

    A) TOXICITY: Significant caustic injury from household products is rare and is only likely to develop after large, deliberate ingestions by adults. Respiratory injury from evolved chlorine or chloramine gas is more likely to develop in closed spaces. A woman developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. She recovered following supportive care.

Summary Of Exposure

    A) USES: Hypochlorite is an aqueous solution produced via the reaction of chlorine gas with water. Most household bleach solutions contain 3% to 5% hypochlorite, while swimming pool disinfectants and industrial strength cleaners may contain up to 20% hypochlorite. Addition of an acid to a hypochlorite solution may release chlorine gas, while the ammonia may react with hypochlorite solutions to release chloramine, a gas with properties similar to chlorine. This scenario most often develops when several different household cleaning products are mixed.
    B) TOXICOLOGY: Dilute aqueous hypochlorite solutions (3% to 5%) may be moderately irritating to the skin but rarely cause serious burns, unless very large volumes are ingested. More concentrated industrial cleaners (20% hypochlorite) may cause more serious corrosive injuries. Both chlorine and chloramine gas are pulmonary irritants and produce a corrosive effect on contact with moist tissues (eg, eyes, upper respiratory tract). Chloramine is less water soluble than chlorine and may produce more delayed effects.
    C) EPIDEMIOLOGY: There are thousands of annual exposures in the United States to hypochlorite solutions, but only a small percentage seeks medical attention, and outcomes are rarely serious.
    D) WITH POISONING/EXPOSURE
    1) MILD TO MODERATE POISONING: Ingestion of dilute (3% to 5%) aqueous hypochlorite solutions will cause immediate burning in the mouth and throat, but no further injury would be expected.
    2) SEVERE POISONING: Ingestions of more concentrated solutions may cause significant esophageal and gastric burns, and patients may manifest dysphagia, drooling, and severe throat, chest, and abdominal pain. Hematemesis and gastrointestinal perforations can occur.
    3) INHALATION: Most common respiratory symptoms included cough, upper respiratory irritation, and dyspnea. Reaction of an acid with a hypochlorite solution liberates chlorine gas, which has relatively high water solubility. This leads to an irritant effect on the mucous membranes (eg, eyes, nose, and throat) of those nearby and may trigger wheezing and other respiratory symptoms, particularly in those with preexisting diseases such as asthma or COPD. In serious exposures, which are rare with household products, upper airway edema may cause obstruction, and lethal noncardiogenic pulmonary edema (chemical pneumonitis) may also occur.
    4) INTRAVENOUS: Acute renal injury, intravascular hemolysis, and mild myocardial injury developed after parenteral self-administration of a large quantity of sodium hypochlorite.
    5) OCULAR OR DERMAL: Ocular or dermal exposures to chlorine gas or hypochlorite solutions can cause irritation and corrosive injuries.

Vital Signs

    3.3.3) TEMPERATURE
    A) WITH POISONING/EXPOSURE
    1) FEVER: In 1 case series (n=24), fever developed in 3 persons (13%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).

Heent

    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) EYE IRRITATION: A transient burning sensation, pain, and lacrimation are common after exposure to chloramine gas or splash exposure (Yigit et al, 2009; Ingram, 1990).
    2) CORNEAL INJURY: Corneal edema and epithelial erosions may develop from swimming in chlorinated water (Haag & Gieser, 1983). Superficial punctate keratopathy has been reported after splash exposure to sodium hypochlorite (Ingram, 1990).
    a) ANIMAL STUDY: In rabbits, delay in irrigation following hypochlorite exposure results in severe corneal and conjunctival edema, and conjunctival hemorrhage, resolving in 1 week (Grant, 1986).
    3) CASE SERIES: In 1 case series (n=24), burning eyes (n=22; 92%), watery eyes (n=19; 79%), blurry eyes (n=8; 33%), and photophobia (n=1; 4%) developed after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    3.4.5) NOSE
    A) WITH POISONING/EXPOSURE
    1) CASE SERIES: In 1 case series (n=24), burning inside the nose developed in 13 persons (54%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) BURNS: Most large series describe a low incidence of corrosive burns to the oropharynx following ingestion of liquid household bleach and related chlorine active compounds (Landau & Saunders, 1964; Pike et al, 1963).
    2) STENOSIS: The incidence of stenosis is even more rare (Landau & Saunders, 1964; Pike et al, 1963; Strange et al, 1951) Yarington, 1965. Strictures were noted in 2 of 160 patients after household bleach ingestion in 1 series (French et al, 1970). In 2 other large series involving 522 patients, no esophageal strictures occurred (Landau & Saunders, 1964; Pike et al, 1963).
    3) TISSUE NECROSIS: Sodium hypochlorite has produced extreme pain, edema, hematoma formation, and local necrosis when improperly injected during root canal procedures (Mehra et al, 2000; Becking, 1991; Becker et al, 1974).
    4) CASE SERIES: In 1 case series (n=24), sore throat developed in 20 persons (83%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) SHOCK
    1) WITH POISONING/EXPOSURE
    a) Rare cases of cardiovascular collapse and shock are presumed to occur secondary to severe local injury from large amounts or concentrated solutions (Gosselin et al, 1984).
    b) CASE REPORT: A 61-year-old woman developed a cardiopulmonary arrest during dialysis when sodium hypochlorite was inadvertently added to the dialysis bath while she was actively being dialyzed (Hoy, 1981).
    B) CARDIOVASCULAR INJURY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An 18-year-old woman with a medical history of depression, anxiety, and chronic Lyme disease developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. She presented with black urine and drowsiness less than 2 hours after self-administration. Laboratory results revealed a troponin of 1.88 ng/mL (normal, less than 0.03). Following supportive care, her hemolysis and myocardial injury resolved over the next 96 hours; however, she continued to be anuric and azotemic. Her renal function gradually recovered after 7 hemodialysis sessions (Verma et al, 2013).
    C) TAKOTSUBO CARDIOMYOPATHY
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 72-year-old woman with a medical history of diabetes, hypertension, and allergic asthma, presented with acute onset dyspnea after inhaling toxic fumes from 2 drain cleaners, one containing sodium hypochlorite/sodium hydroxide and the other possibly hydrochloric acid. An initial resting ECG revealed diffuse ST-elevation, mainly in anterior leads, and diphasic T-waves. Laboratory results showed markedly elevated Nt-proBNP (N-terminal of the prohormone of brain natriuretic peptide) levels (14.435 pg/mL, normal values less than 450) and mildly elevated troponin levels (2.37 ng/mL; normal values less than 0.07). An echocardiograph showed the typical signs of left ventricular apical ballooning with hyperkinesis of left ventricular basal segments (left ventricular ejection fraction 40%). A coronary angiography revealed mild coronary atherosclerosis, not requiring coronary angioplasty. Following supportive care, she was discharged home a week later with near-complete recovery of left ventricular systolic dysfunction (De Gennaro et al, 2015).

Respiratory

    3.6.2) CLINICAL EFFECTS
    A) RESPIRATORY FINDING
    1) WITH POISONING/EXPOSURE
    a) Dyspnea and cough are common after inhalation of chloramine or chlorine gas formed by mixing bleach with ammonia or acids (De Gennaro et al, 2015; Yigit et al, 2009; Mrvos et al, 1993; Reisz & Gammon, 1986; Gapany-Gapanavicius et al, 1982) . Most common respiratory symptoms included cough, upper respiratory irritation, and dyspnea (Centers for Disease Control and Prevention, 2011).
    b) Decreases in FVC, FEV1, and peak expiratory flow rates developed in volunteers exposed to 1 ppm of chlorine gas (Rotman et al, 1983). Patients developing significant pulmonary injury after inhaling chloramine gas from mixing household bleach with ammonia have developed persistent decreases in pulmonary function (Reisz & Gammon, 1986).
    c) Another case of significant exposure and acute pulmonary effects did not result in residual pulmonary function abnormalities (Heidemann & Goetting, 1991).
    d) Ingestion of pool sterilizing tablets or inhalation of their fumes may produce similar symptoms (Wood et al, 1987; Phillip et al, 1985; Siodlak et al, 1985) .
    e) CASE REPORT: A 34-year-old man presented with shortness of breath and first- and second-degree facial burns after a mixture of calcium hypochlorite (65% chlorine) and water exploded. Arterial blood gas analysis showed pH 7.39, pCO2 41 mmHg, pO2 57 mmHg on room air. Following supportive care, including steroid therapy and nebulized short-acting beta-agonists, he recovered and was discharged after 3 days (Yigit et al, 2009).
    f) CASE SERIES: In 1 case series (n=24), coughing (n=19; 79%), sneezing (n=18; 75%), wheezing (n=11; 46%), chest tightness (n=7; 29%), and shortness of breath (n=5; 21%) developed after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    1) A 6-year-old boy developed cough, dyspnea, vomiting, erythematous eyes and nasopharynx, inspiratory stridor, wheezing, and respiratory distress (oxygen saturation 98%) after exposure to an indoor motel swimming pool. At the pediatric ICU, he was diagnosed with upper airway obstruction from chemical epiglottitis and laryngotracheobronchitis. His condition gradually improved with supportive therapy, and he was discharged the next day (Center for Disease Control and Prevention, 2007).
    g) CASE SERIES: Twenty-five of 48 individuals exposed to chlorine gas released during disinfection of a swimming pool toilet with bleach and sulfuric acid experienced symptoms consisting of tachypnea, wheezing, cough, chest pain, sore throat, nausea, vomiting, conjunctival irritation, or headaches. No residual pulmonary effects occurred (Phillip et al, 1985).
    h) CASE SERIES: A retrospective study of 216 cases of chlorine and chloramine gas inhalation resulting from the mixing of cleaning products (hypochlorites with acids, ammonia, or alkalis) reported the following (Mrvos et al, 1993):
    1) COMMON SIGNS AND SYMPTOMS: Cough is most common; dyspnea, throat irritation, chest pain, wheezing, dizziness, vomiting, ocular irritation, nasal irritation, and abdominal pain are also frequent. Thirteen percent of cases who detected the chlorine/chloramine gas odor were asymptomatic.
    2) CHEST RADIOGRAPHS: Chest radiographs were normal in 68 out of 69 cases.
    3) ARTERIAL BLOOD GASES: Arterial blood gases were normal in 41 out of 41 cases.
    4) OUTCOME: Complete resolution in 10% of symptomatic patients within 1 hour; resolution in 1 to 6 hours in 76% of cases; resolution greater than 6 hours in 8% of cases. Most individuals with preexisting cardiac or pulmonary problems recovered within 6 hours (5 refused treatment in emergency department [ED], 18 treated in ED). One patient required treatment beyond 6 hours.
    B) BRONCHOSPASM
    1) WITH POISONING/EXPOSURE
    a) Airway edema with stridor and bronchospasm may develop after chlorine or chloramine inhalation or ingestion of sterilizing tablets (Heidemann & Goetting, 1991; Reisz & Gammon, 1986; Siodlak et al, 1985; Gapany-Gapanavicius et al, 1982).
    b) Supraglottic edema and edema of the aryepiglottic fold and hypopharynx were reported in 2 children who ingested pool sterilizing tablets (Siodlak et al, 1985).
    c) Exacerbation of asthma occurred in 1 case exposed to chlorine gas generated from the mixing of sodium hypochlorite and phosphoric acid (MMWR, 1991).
    C) PNEUMONIA
    1) WITH POISONING/EXPOSURE
    a) Pneumonitis, which can progress to acute respiratory distress syndrome (ARDS), has developed in individuals inhaling chloramine and chlorine gas from mixing cleaning products or inhaling fumes from pool sterilizer tablets (Wood et al, 1987; Reisz & Gammon, 1986; ITI, 1985).
    b) Radiographic findings may lag behind clinical symptoms and may resolve slowly (Reisz & Gammon, 1986; Gapany-Gapanavicius et al, 1982a).
    c) CASE REPORT: Severe chemical pneumonitis has been reported from chloramine gas produced by mixing household ammonia and bleach in a poorly ventilated area (Gapany-Gapanavicius et al, 1982a).
    d) CASE SERIES: Life-threatening pneumonitis, requiring supplemental oxygen or mechanical ventilation, was described in 3 women after prolonged cleaning (3 hours to 3 days) with household ammonia and bleach mixtures. All 3 had residual interstitial infiltrates and dyspnea on exertion on follow-up 21 days to 9 months after discharge (Reisz & Gammon, 1986).
    D) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) Pulmonary edema, which can progress to acute hypoxemic respiratory failure, can occur from chlorine gas inhalation (Heidemann & Goetting, 1991).
    b) CASE SERIES: In a case series involving over 500 cases reported to the CDC over a 6 year period, 5 high-severity cases were identified. All patients were exposed to potent hypochlorite solutions which caused cough, dyspnea, upper and lower respiratory irritation, pulmonary edema, and asthma exacerbation. Cyanosis also developed in a 5 year-old boy exposed to calcium hypochlorite (concentration 65%). All patients were treated with supportive medical care and survived (Centers for Disease Control and Prevention, 2011).
    c) CASE REPORT: A 33-year-old woman presented to the ED without respiratory symptoms following assault with a bleach solution containing sodium hypochlorite. The initial chest x-ray, performed 2 hours postingestion, showed bilateral bibasilar infiltrates. The patient's condition deteriorated rapidly, necessitating mechanical ventilation. A repeat chest x-ray showed the development of ARDS, worsening over the next 24 hours. She slowly recovered with supportive care (26 days of mechanical ventilation) (Bracco et al, 2005)
    E) APNEA
    1) WITH POISONING/EXPOSURE
    a) Acute hypoxemic respiratory failure or respiratory distress syndrome has developed in individuals inhaling chloramine and chlorine gas from mixing cleaning products or from inhaling fumes from pool sterilizer tablets (Heidemann & Goetting, 1991; Wood et al, 1987; Reisz & Gammon, 1986; ITI, 1985) .
    b) Criteria for acute hypoxemic respiratory failure has included severe hypoxemia despite oxygen administration, chest x-ray showing diffuse pulmonary infiltrates, decreased lung compliance with intrapulmonary shunt, and normal cardiac function despite low (less than 18 mmHg) pulmonary artery occlusive pressure (Heidemann & Goetting, 1991).
    F) DISORDER OF RESPIRATORY SYSTEM
    1) WITH POISONING/EXPOSURE
    a) Pneumomediastinum developed in 2 patients who inhaled chlorine gas after mixing sodium hypochlorite with acid (Gapany-Gapanavicius et al, 1982b).
    b) CASE SERIES: Cleaning workers exposed to lower airborne concentration (0.4 ppm) of sodium hypochlorite (bleach) experienced decreased FEV1 measurements (Sastre et al, 2011).
    G) SUPRAGLOTTIC EDEMA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 53-year-old woman developed shortness of breath after cleaning with liquid ammonia and bleach in a closed walk-in freezer. She progressed to throat tightness and inability to speak despite treatment with nebulized albuterol, racemic epinephrine, and intravenous steroids. Rapid sequence intubation was unsuccessful secondary to upper airway edema, and she required emergency tracheostomy. She developed radiographic evidence of pneumonitis over 4 hours and recovered over the next 7 days (Tanen et al, 1999).
    b) CASE REPORT: An 18-month-old child developed vomiting and coughing immediately after ingesting household bleach. She progressed to stridor and wheezing, initially responsive to racemic epinephrine and dexamethasone. Stridor increased despite continuous racemic epinephrine, and laryngoscopy revealed glottic and subglottic edema without supraglottic swelling. She was intubated for 72 hours and recovered with supportive care (Babl et al, 1998).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) DROWSY
    1) WITH POISONING/EXPOSURE
    a) Lethargy occurs in patients with severe pneumonitis and hypoxia following inhalation of chlorine or chloramine gas (Wood et al, 1987; Reisz & Gammon, 1986).
    B) COMA
    1) WITH POISONING/EXPOSURE
    a) Coma occurred in an 18-month-old female following ingestion of several tablespoonfuls of household bleach and treatment with vinegar lavage (Gosselin et al, 1984a).
    b) Coma developed in a 12-year-old after inhalation of chlorine gas, which resulted in pulmonary edema and respiratory failure (Heidemann & Goetting, 1991).
    C) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) Seizures developed in an adult following ingestion of 121 g of sodium hypochlorite in solution (Hilbert & Bedry, 1994).
    D) ABSENCE OF SENSATION
    1) WITH POISONING/EXPOSURE
    a) NERVE BLOCK: Anesthesia and paresthesia of the mental nerve have developed after injection of sodium hypochlorite beyond the root apex during root canal procedures. Return of normal sensation may take months (Becking, 1991).
    b) CASE REPORTS: Paresthesia of the right infraorbital nerve with weakness of the buccal branch of the facial nerve resulting in some loss of cheek and upper lip function was observed in 1 patient after inadvertent extrusion of sodium hypochlorite following a root canal procedure. Complete resolution occurred after approximately 6 months. In another patient, paresthesia of the right infraorbital nerve distribution with weakness of the buccal branch of the facial nerve resulting in drooping of the right corner of the mouth was reported after extrusion of sodium hypochlorite following a root canal procedure. At 3 months, both facial weakness and paresthesia had completely resolved (Witton et al, 2005).
    E) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: In 1 case series (n=24), headache developed in 18 persons (75%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).

Gastrointestinal

    3.8.2) CLINICAL EFFECTS
    A) GASTROINTESTINAL TRACT FINDING
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: In 1 case series (n=24), dry mouth (n=8; 33%), nausea (n=7; 29%), diarrhea (n=7; 29%), vomiting (n=4; 17%), and abdominal cramping (n=2; 18%) developed after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    B) CHEMICAL BURN
    1) WITH POISONING/EXPOSURE
    a) Significant gastrointestinal burns after ingestion of household bleach are unusual, but burns of the stomach and esophagus have been reported (Jakobsson et al, 1991a; Yarington et al, 1964; Strange et al, 1951; French et al, 1970) .
    b) CASE REPORT CHILD: A 1-year-old child developed extensive necrosis of the face, nose, oropharynx, esophagus, and stomach after allegedly ingesting a household cleanser containing sodium hypochlorite 4.5%. The presence of the cleaning product in the stomach was confirmed at autopsy. It was believed that the child ingested a large amount of the product in an abusive situation (Jakobsson et al, 1991).
    c) CASE REPORT ADULT: A 32-year-old woman developed necrosis of the upper gastrointestinal tract with evidence of esophageal and gastric perforation after ingesting 750 mL of a sodium hypochlorite solution (Hilbert & Bedry, 1994; Hilbert et al, 1997).
    d) CASE REPORT: A 66-year-old woman developed hypernatremia (169 mEq/L), hyperchloremia (143 mEq/L), and metabolic acidosis (pH 7.18, pCO2 19, CO2 5 mEq/L) after ingesting half a bottle of 5% to 10% sodium hypochlorite. She presented with slurred speech and a black tongue and rapidly became lethargic, incoherent, and then unresponsive. She developed a hemopneumothorax and gastric perforation and died 5 hours after ingestion (Spiller et al, 1994).
    e) CASE SERIES: In a series of 74 children with household bleach ingestion who underwent endoscopy, 8 (10.7%) had grade 1 esophageal burns and the others had no evidence of gastrointestinal injury. No child developed strictures (Kiristioglu et al, 1999).
    f) The vast majority of patients ingesting household bleach do not develop significant toxicity (Racioppi et al, 1994).
    C) STRICTURE OF ESOPHAGUS
    1) WITH POISONING/EXPOSURE
    a) Strictures of the gastrointestinal tract are unusual following ingestion of household bleach (Pike et al, 1963; Landau & Saunders, 1964).
    b) There are 2 reports in the literature of esophageal stricture and 2 of gastric outlet obstruction developing after ingestion of bleach. Three of these were deliberate ingestions of large amounts by adults (Van Rhee & Beaumont, 1990; French et al, 1970; Strange et al, 1951) .
    D) VOMITING
    1) WITH POISONING/EXPOSURE
    a) Spontaneous emesis is common after hypochlorite ingestion or chlorine or chloramine gas inhalation (Mrvos et al, 1993) Galpany-Gapanavicius et al, 1982a;(French et al, 1970).
    b) CASE REPORT: A 42-year-old paraplegic man with a history of multiple gunshot wounds and osteomyelitis developed vomiting, pain, and transient rhabdomyolysis (CK 6000 international units/L, urine myoglobin 120 mg/dL) after self-administration of 20 mL of liquid household bleach (sodium hypochlorite 5.25%) into his port-a-cath. Following supportive care, he recovered fully with no permanent sequelae (Tuckler et al, 2002).
    c) CASE SERIES: In 1 case series (n=24), vomiting developed in 4 persons (17%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 ppm) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).

Genitourinary

    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: An 18-year-old woman with a medical history of depression, anxiety, and chronic Lyme disease developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. She presented with black urine and drowsiness less than 2 hours after self-administration. Laboratory results revealed blood urea nitrogen of 23 mg/dL (normal range, 7 to 23), serum creatinine of 2.99 mg/dL (normal range, 0.5 to 1.2), bilirubin of 2.3 mg/dL (normal range, 0.3 to 1.2), serum lactate dehydrogenase of 1984 international Units/L (normal range, 110 to 240), prothrombin time of 28.5 s (normal range, 9.6 to 12.5), activated partial thromboplastin time of 46 s (normal range, 22.3 to 34), and troponin of 1.88 ng/mL (normal, less than 0.03). Following supportive care, her hemolysis and myocardial injury resolved over the next 96 hours; however, she continued to be anuric and azotemic. On day 4, a kidney biopsy showed extensive loss of the proximal tubular epithelium with anucleate cellular debris compatible with hemolyzed erythrocytes and interstitium containing focal acute inflammatory infiltrates surrounding the necrotic tubules. Her renal function gradually recovered after 7 hemodialysis sessions (starting on day 2) (Verma et al, 2013).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: Hyperchloremic acidosis (pH 7.25) was reported in a 66-year-old woman after massive bleach ingestion (Ward & Routledge, 1988).
    b) CASE REPORT: Metabolic acidosis (pH 6.8), in the absence of pulmonary signs or symptoms, was reported in a 40-year-old woman following cleaning of a toilet with bleach and then an acidic detergent for 30 minutes. The sewage tank connected to the toilet contained large amounts of urea and ammonia, thus both chlorine gas and chloramine gas were suspected to have been formed (Minami et al, 1992).
    c) CASE REPORT: Metabolic acidosis occurred in a 12-year-old following chlorine gas inhalation, which also produced coma and respiratory failure (Heidemann & Goetting, 1991).
    d) CASE REPORT: A 32-year-old woman developed metabolic acidosis (pH 7.15, bicarbonate 12 mmol/L) after ingesting 750 mL of a 13.3% sodium hypochlorite solution (Hilbert et al, 1997).
    e) CASE REPORT: A 66-year-old woman developed hypernatremia (169 mEq/L), hyperchloremia (143 mEq/L), and metabolic acidosis (pH 7.18, pCO2 19, CO2 5 mEq/L) after ingesting half a bottle of 5% to 10% sodium hypochlorite. She presented with slurred speech and a black tongue and rapidly became lethargic, incoherent, and then unresponsive. She developed a hemopneumothorax and gastric perforation and died 5 hours after ingestion (Spiller et al, 1994).

Hematologic

    3.13.2) CLINICAL EFFECTS
    A) HEMOLYSIS
    1) WITH POISONING/EXPOSURE
    a) Significant hemolysis has been reported when public drinking water purified with chloramine was used in home dialysis (Davis et al, 1984; Kjellstrand et al, 1974; Eaton et al, 1973). Sodium hypochlorite introduced into a dialysis bath has produced massive hemolysis (Hoy, 1981).
    b) To prevent bacterial contamination, chloramines are usually added to municipal water (acceptable levels less than 0.1 mg/L). Because chloramines can cause red blood cell oxidant damage, resulting in the conversion of hemoglobin to methemoglobin and subsequent hemolysis, these agents should be removed from water in dialysis facilities (De Torres et al, 2002).
    c) CASE REPORT: An 18-year-old woman with a medical history of depression, anxiety, and chronic Lyme disease developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. She presented with black urine and drowsiness less than 2 hours after self-administration. Laboratory results revealed blood urea nitrogen of 23 mg/dL (normal range, 7 to 23), serum creatinine of 2.99 mg/dL (normal range, 0.5 to 1.2), bilirubin of 2.3 mg/dL (normal range, 0.3 to 1.2), serum lactate dehydrogenase of 1984 international Units/L (normal range, 110 to 240), prothrombin time of 28.5 s (normal range, 9.6 to 12.5), activated partial thromboplastin time of 46 s (normal range, 22.3 to 34), and troponin of 1.88 ng/mL (normal, less than 0.03). Following supportive care, her hemolysis and myocardial injury resolved over the next 96 hours; however, she continued to be anuric and azotemic. Her renal function gradually recovered after 7 hemodialysis sessions (starting on day 2) (Verma et al, 2013).
    B) METHEMOGLOBINEMIA
    1) WITH POISONING/EXPOSURE
    a) Hemodialysis-associated methemoglobinemia, believed to be secondary to chloramine contamination, has been reported in 2 patients with acute renal failure (De Torres et al, 2002).
    1) An 82-year-old man with acute renal failure, metabolic acidosis, hyperkalemia, and anemia developed cyanosis (pulse oximetry desaturation less than 80%) during his third hemodialysis treatment. An arterial blood gas on 100% oxygen showed a PaO2 of 416 mmHg and a measured oxygen saturation of 94%. Methemoglobin level of 4.4% of hemoglobin (normal range, 0% to 1.5%) was obtained on the same sample. A Heinz body assay for hemolysis was positive; elevated serum lactate dehydrogenase and indirect bilirubin were also observed. Because inadequate chloramine decontamination by a portable dialysis system was suspected, the carbon filtration unit was enlarged. Immediately after hemodialysis, an arterial methemoglobin was 0.2% (De Torres et al, 2002).
    2) Another patient, a 77-year-old woman with a history of breast cancer and COPD, was admitted to the medical intensive care unit with suspected hemolytic uremic syndrome. Hemodialysis and plasmapheresis were initiated for acute renal failure and thrombocytopenia. She developed cyanosis (pulse oximetry less than 80%) during the second hemodialysis treatment. An arterial blood gas on 50% oxygen showed a PaO2 of 103 mmHg with an oxygen saturation of 95%; co-oximetry showed a methemoglobin level of 6.4% of hemoglobin. A Heinz body assay for hemolysis was positive; elevated serum lactate dehydrogenase and indirect bilirubin were also observed. Inadequate chloramine decontamination by a portable dialysis system was suspected and the carbon filtration unit was enlarged. Immediately after hemodialysis, a methemoglobin level was 1% (De Torres et al, 2002).

Dermatologic

    3.14.2) CLINICAL EFFECTS
    A) DERMATITIS
    1) WITH POISONING/EXPOSURE
    a) Allergic dermatitis has been reported with several chlorine active compounds (Fisher, 1984).
    B) INJECTION SITE REACTION
    1) WITH POISONING/EXPOSURE
    a) Injection site erythema developed in a 31-year-old man after IV injection of about 0.3 mL of sodium hypochlorite 5.25% into the right and left antecubital vein. Left-sided chest pain, vomiting, and mild hypertension occurred. Blood gases, EKG, electrolytes, and urinalysis were normal; ethanol level was 135 mg/dL. The patient had no serious adverse effects and was released after 6 hours (Morgan, 1992).
    C) ERUPTION
    1) WITH POISONING/EXPOSURE
    a) CASE SERIES: In 1 case series (n=24), skin rash developed in 4 persons (17%) after exposure to an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 parts per million [ppm]) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    D) BURN
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 34-year-old man presented with respiratory symptoms and first- and second-degree facial burns after a mixture of calcium hypochlorite (65% chlorine) and water exploded. Following supportive care, he recovered and was discharged after 3 days (Yigit et al, 2009).

Musculoskeletal

    3.15.2) CLINICAL EFFECTS
    A) RHABDOMYOLYSIS
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 42-year-old paraplegic man with a history of multiple gunshot wounds and osteomyelitis developed vomiting, pain, and transient rhabdomyolysis (CK 6,000 international units/L, urine myoglobin 120 mg/dL) after the self-administration of 20 mL of liquid household bleach (sodium hypochlorite 5.25%) into his port-a-cath. Following supportive care, he recovered fully with no permanent sequelae (Tuckler et al, 2002).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Obtain a chest radiograph and monitor pulse oximetry and arterial blood gases in patients with respiratory signs or symptoms. Further imaging studies may be required for patients with a history of a large or high concentration ingestion, especially if there is concern for perforation (eg, x-rays, endoscopy, esophagram).
    B) Monitor electrolytes in patients with large ingestions of sodium hypochlorite.
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) Serum electrolytes (particularly sodium and chloride) and blood gases should be monitored in patients with substantial sodium hypochlorite ingestions.
    4.1.4) OTHER
    A) OTHER
    1) MONITORING
    a) Pulse oximetry or arterial blood gases and pulmonary function tests should be monitored in patients with significant pulmonary symptoms.
    b) Chest radiographs are indicated in patients with significant pulmonary symptoms.
    c) Endoscopy is indicated in rare patients with significant symptoms (eg, pain, dysphagia, hematemesis) or with large ingestions. Endoscopy may also be indicated in patients ingesting granular bleach or industrial strength products.

Methods

    A) OTHER
    1) Aside from supportive laboratory procedures, no specific analytical assistance is available.
    B) LABORATORY INTERFERENCE
    1) Dissolved permanganate has caused false-positive results for chloramines in granular activated carbon-treated water at dialysis centers (Cohn et al, 2005).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients with persistent symptoms after a period of observation and supportive treatment should be admitted to the hospital. Depending on the severity of the symptoms (eg, intubation for pulmonary edema), an ICU bed may be needed. Criteria for hospital discharge should be improvement or resolution of symptoms.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Patients with minimal inadvertent exposures who remain asymptomatic or develop mild symptoms with resolution may remain at home.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Depending on the route of exposure and symptoms, it may be appropriate to consult a burn specialist, gastroenterologist, ophthalmologist, or intensivist. For large-scale exposures, public health and hazardous materials personnel should be notified. A poison center, medical toxicologist, or both should be contacted for moderate to severe exposures.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) All patients with persistent symptoms or intentional exposures should be sent to a health care facility for observation for the longer of 4 to 6 hours or until symptoms resolve. Criteria for discharge should include symptom resolution.

Monitoring

    A) Obtain a chest radiograph and monitor pulse oximetry and arterial blood gases in patients with respiratory signs or symptoms. Further imaging studies may be required for patients with a history of a large or high concentration ingestion, especially if there is concern for perforation (eg, x-rays, endoscopy, esophagram).
    B) Monitor electrolytes in patients with large ingestions of sodium hypochlorite.

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) Dilute with small amounts of milk or water following an ingestion. Activated charcoal is CONTRAINDICATED. Remove contaminated clothing, wash exposed skin, and irrigate exposed eyes with normal saline or water.
    6.5.2) PREVENTION OF ABSORPTION
    A) Gastric aspiration could be helpful for large and relatively recent ingestions of high concentration hypochlorite solutions, but this entails the potential risk of damage to a burned esophagus.
    B) DILUTION
    1) DILUTION: If no respiratory compromise is present, administer milk or water as soon as possible after ingestion. Dilution may only be helpful if performed in the first seconds to minutes after ingestion. The ideal amount is unknown; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children is recommended to minimize the risk of vomiting (Caravati, 2004).
    6.5.3) TREATMENT
    A) SUPPORT
    1) MANAGEMENT OF MILD TO MODERATE TOXICITY
    a) Supportive care and removal from exposure or decontamination are the mainstays of treatment. Remove contaminated clothing and copiously irrigate exposed eyes or skin with water or saline. Patients with respiratory exposures should leave the area of exposure immediately and receive supplemental oxygen, bronchodilators, and advanced airway support (eg, intubation) as necessary. Nebulized sodium bicarbonate (3.75%) has been used to treat respiratory irritation after chlorine inhalation in some cases and is suggested by some experts. Dilute with small amounts of milk or water following an ingestion.
    2) MANAGEMENT OF SEVERE TOXICITY
    a) Standard burn care should be applied for serious ocular and dermal corrosive effects. Severe respiratory distress requires intubation. For ingestions of hypochlorite solutions greater than 10% or symptoms of severe corrosive injuries (ie, dysphagia, drooling, pain), flexible endoscopy should be performed to evaluate the extent of esophageal or gastric injury. Chest and abdominal x-rays may be useful to look for mediastinal or intraabdominal free air secondary to perforations in the gastrointestinal tract, which require surgical intervention.
    B) MONITORING OF PATIENT
    1) Obtain a chest radiograph and monitor pulse oximetry and arterial blood gases in patients with respiratory signs or symptoms. Further imaging studies may be required for patients with a history of large or high concentration ingestion, especially if there is concern for perforation (eg, x-rays, endoscopy, esophagram).
    2) Monitor electrolytes in patients with large ingestions of sodium hypochlorite.
    C) DILUTION
    1) DILUTION: If no respiratory compromise is present, administer milk or water as soon as possible after ingestion. Dilution may only be helpful if performed in the first seconds to minutes after ingestion. The ideal amount is unknown; no more than 8 ounces (240 mL) in adults and 4 ounces (120 mL) in children is recommended to minimize the risk of vomiting (Caravati, 2004).
    2) NEUTRALIZATION
    a) CONTRAINDICATED: Administration of acids or basic substances for neutralization is contraindicated due to the possibility of exothermic reaction and subsequent burning.
    D) ENDOSCOPY OF ESOPHAGUS
    1) Consultation with a gastroenterologist or surgeon should be obtained to determine if esophagoscopy is indicated in patients who are drooling, complaining of pain, or otherwise demonstrating the possibility of significant burns.
    2) Esophagoscopy is rarely needed following ingestion of small amounts of household liquid bleach. Ingestion of large amounts (greater than or equal to 5 mL/kg) of household bleach, commercial bleach, or bleach granule may necessitate esophagoscopy.
    3) CASE SERIES: In a series of 74 children with household bleach ingestion who underwent endoscopy, 8 (10.7%) had grade 1 esophageal burns and the others had no evidence of gastrointestinal injury. No child developed strictures (Kiristioglu et al, 1999).

Inhalation Exposure

    6.7.1) DECONTAMINATION
    A) Move patient from the toxic environment to fresh air. Monitor for respiratory distress. If cough or difficulty in breathing develops, evaluate for hypoxia, respiratory tract irritation, bronchitis, or pneumonitis.
    B) OBSERVATION: Carefully observe patients with inhalation exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.
    C) INITIAL TREATMENT: Administer 100% humidified supplemental oxygen, perform endotracheal intubation and provide assisted ventilation as required. Administer inhaled beta-2 adrenergic agonists, if bronchospasm develops. Consider systemic corticosteroids in patients with significant bronchospasm (National Heart,Lung,and Blood Institute, 2007). Exposed skin and eyes should be flushed with copious amounts of water.
    6.7.2) TREATMENT
    A) OXYGEN
    1) Administer 100% humidified supplemental oxygen with assisted ventilation to patients with respiratory tract irritation, as required.
    B) BRONCHODILATOR
    1) BRONCHOSPASM SUMMARY
    a) Administer beta2 adrenergic agonists. Consider use of inhaled ipratropium and systemic corticosteroids. Monitor peak expiratory flow rate, monitor for hypoxia and respiratory failure, and administer oxygen as necessary.
    2) ALBUTEROL/ADULT DOSE
    a) 2.5 to 5 milligrams diluted with 4 milliliters of 0.9% saline by nebulizer every 20 minutes for three doses. If incomplete response, administer 2.5 to 10 milligrams every 1 to 4 hours as needed OR administer 10 to 15 milligrams every hour by continuous nebulizer as needed. Consider adding ipratropium to the nebulized albuterol; DOSE: 0.5 milligram by nebulizer every 30 minutes for three doses then every 2 to 4 hours as needed, NOT administered as a single agent (National Heart,Lung,and Blood Institute, 2007).
    3) ALBUTEROL/PEDIATRIC DOSE
    a) 0.15 milligram/kilogram (minimum 2.5 milligrams) diluted with 4 milliliters of 0.9% saline by nebulizer every 20 minutes for three doses. If incomplete response administer 0.15 to 0.3 milligram/kilogram (maximum 10 milligrams) every 1 to 4 hours as needed OR administer 0.5 mg/kg/hr by continuous nebulizer as needed. Consider adding ipratropium to the nebulized albuterol; DOSE: 0.25 to 0.5 milligram by nebulizer every 20 minutes for three doses then every 2 to 4 hours as needed, NOT administered as a single agent (National Heart,Lung,and Blood Institute, 2007).
    4) ALBUTEROL/CAUTIONS
    a) The incidence of adverse effects of beta2-agonists may be increased in older patients, particularly those with pre-existing ischemic heart disease (National Asthma Education and Prevention Program, 2007). Monitor for tachycardia, tremors.
    5) CORTICOSTEROIDS
    a) Consider systemic corticosteroids in patients with significant bronchospasm. PREDNISONE: ADULT: 40 to 80 milligrams/day in 1 or 2 divided doses. CHILD: 1 to 2 milligrams/kilogram/day (maximum 60 mg) in 1 or 2 divided doses (National Heart,Lung,and Blood Institute, 2007).
    C) CORTICOSTEROID
    1) The role of corticosteroids in the treatment of chemical pneumonitis is controversial.
    D) ACUTE LUNG INJURY
    1) ONSET: Onset of acute lung injury after toxic exposure may be delayed up to 24 to 72 hours after exposure in some cases.
    2) NON-PHARMACOLOGIC TREATMENT: The treatment of acute lung injury is primarily supportive (Cataletto, 2012). Maintain adequate ventilation and oxygenation with frequent monitoring of arterial blood gases and/or pulse oximetry. If a high FIO2 is required to maintain adequate oxygenation, mechanical ventilation and positive-end-expiratory pressure (PEEP) may be required; ventilation with small tidal volumes (6 mL/kg) is preferred if ARDS develops (Haas, 2011; Stolbach & Hoffman, 2011).
    a) To minimize barotrauma and other complications, use the lowest amount of PEEP possible while maintaining adequate oxygenation. Use of smaller tidal volumes (6 mL/kg) and lower plateau pressures (30 cm water or less) has been associated with decreased mortality and more rapid weaning from mechanical ventilation in patients with ARDS (Brower et al, 2000). More treatment information may be obtained from ARDS Clinical Network website, NIH NHLBI ARDS Clinical Network Mechanical Ventilation Protocol Summary, http://www.ardsnet.org/node/77791 (NHLBI ARDS Network, 2008)
    3) FLUIDS: Crystalloid solutions must be administered judiciously. Pulmonary artery monitoring may help. In general the pulmonary artery wedge pressure should be kept relatively low while still maintaining adequate cardiac output, blood pressure and urine output (Stolbach & Hoffman, 2011).
    4) ANTIBIOTICS: Indicated only when there is evidence of infection (Artigas et al, 1998).
    5) EXPERIMENTAL THERAPY: Partial liquid ventilation has shown promise in preliminary studies (Kollef & Schuster, 1995).
    6) CALFACTANT: In a multicenter, randomized, blinded trial, endotracheal instillation of 2 doses of 80 mL/m(2) calfactant (35 mg/mL of phospholipid suspension in saline) in infants, children, and adolescents with acute lung injury resulted in acute improvement in oxygenation and lower mortality; however, no significant decrease in the course of respiratory failure measured by duration of ventilator therapy, intensive care unit, or hospital stay was noted. Adverse effects (transient hypoxia and hypotension) were more frequent in calfactant patients, but these effects were mild and did not require withdrawal from the study (Wilson et al, 2005).
    7) However, in a multicenter, randomized, controlled, and masked trial, endotracheal instillation of up to 3 doses of calfactant (30 mg) in adults only with acute lung injury/ARDS due to direct lung injury was not associated with improved oxygenation and longer term benefits compared to the placebo group. It was also associated with significant increases in hypoxia and hypotension (Willson et al, 2015).
    E) SODIUM BICARBONATE
    1) SUMMARY
    a) Nebulized sodium bicarbonate (3.75%) has been used to treat respiratory irritation after chlorine inhalation in some cases and is suggested by some experts. Theoretically, the use of sodium bicarbonate may neutralize the acidic products that are formed when the chlorine gas reacts with water (Traub et al, 2002).
    b) PREPARATION: A 3.75% solution of sodium bicarbonate can be prepared by diluting 2 mL of the standard 7.5% sodium bicarbonate intravenous solution with 2 mL normal saline (Vinsel, 1990).
    2) HUMAN
    a) A double-blind, placebo-controlled study was conducted to determine the efficacy of nebulized sodium bicarbonate for treatment of reactive airways dysfunction syndrome (RADS) following chlorine gas inhalation. Forty-four patients with persistent RADS for at least 3 months with initial onset within 24 hours of chlorine gas inhalation were given either nebulized sodium bicarbonate (n=22) or nebulized placebo (n=22). All patients also received corticosteroids and nebulized short-acting beta-agonists. FEV1 values were significantly higher at 120 and 240 minutes in the nebulized sodium bicarbonate group as compared with the nebulized placebo group (p less than 0.05). The quality of life scores in both groups, determined from questionnaires, also improved significantly following treatment (p less than 0.001), but there was no significant difference between the groups (Aslan et al, 2006).
    b) CASE REPORT: A 3-year-old girl developed vomiting and respiratory distress after about 45 seconds of exposure to chlorine gas from 10% to 16% sodium hypochlorite solution and a 15% hydrochloric acid solution, used for pool cleaning. She was treated with nebulized albuterol and was transferred to an emergency department. On presentation, she had cough, tachypnea, increased work of breathing without retractions or wheezing, and a sedate, glassy-eyed look. A chest x-ray showed mild perihilar peribronchial thickening, reportedly consistent with acute or chronic bronchitis. Despite treatment with nebulized albuterol/ipratropium bromide solution, her respiratory distress worsened. Another chest x-ray revealed frank pulmonary edema. At this time, she received nebulized mixture of 3 mL of 8.4% sodium bicarbonate solution and 2 mL of normal saline, resulting in a rapid improvement of breathing. She also received IV corticosteroids an hour later. About 12 hours after sodium bicarbonate use, she was breathing room air (Vajner & Lung, 2013).
    c) CASE SERIES: In a retrospective study, 25 soldiers developed coughing and dyspnea after exposure to chlorine gas (from a mixture of sodium hypochlorite with hydrochloric acid) during cleaning activities. All patients were treated with humidified oxygen and nebulized salbutamol. Nineteen patients also received inhaled budesonide and nebulized sodium bicarbonate. Initially, 13 patients were discharged and 12 patients were hospitalized. These patients were discharged after improvement following supportive care (Cevik et al, 2009).
    d) CASE REPORTS: Dramatic improvement of early respiratory symptoms was noted following humidification with a 5% sodium bicarbonate solution in an anecdotal report (Done, 1976) and with a 3.75% sodium bicarbonate solution in 3 male patients with mild symptoms in another anecdotal report (Vinsel, 1990).
    1) CASE REPORT/PEDIATRIC: A 7-year-old exposed to chlorine fumes showed immediate improvement in her respiratory symptoms after receiving a total concentration of 3.75% sodium bicarbonate solution via nebulizer. The solution was prepared by diluting 2 mL of the standard pediatric IV sodium bicarbonate solution (8.4%) with 2.25 mL of normal saline. A total of 4.25 mL was given over 20 minutes with resolution of symptoms; oxygen saturation remained between 96% and 100% on room air (Douidar, 1997).
    e) CASE SERIES: In a retrospective review of 86 cases of chlorine gas exposure that were treated with nebulized sodium bicarbonate (3 mL of 8.4% sodium bicarbonate mixed with 2 mL normal saline administered as a nebulizer treatment with oxygen or air), 69 patients were treated and released from the emergency department. Of these, 7 also received inhaled bronchodilators, 1 patient received steroids, 2 were discharged with bronchodilators, and 1 patient was discharged with a course of steroids. Condition was improved on discharge in 53 patients, 23 of whom were asymptomatic. Condition was not specified in 16 patients who were treated and released. Seventeen patients required hospital admission. No patient appeared to suffer an adverse effect that could be attributed to sodium bicarbonate (Bosse, 1994).
    f) Steroid and bicarbonate treatments were inadequate supportive therapies for patients with acute chlorine intoxication in a case series of 106 patients (Guloglu et al, 2002).
    g) Clinically, humidification with 5% sodium bicarbonate does not seem to produce a notable thermal reaction within the lung parenchyma. This most likely occurs due to the dilute concentration used.
    3) ANIMAL DATA
    a) A study in sheep that were exposed to chlorine gas for 4 minutes and then randomized to receive 8 mL of nebulized normal saline or 4% sodium bicarbonate demonstrated a higher PCO2 and lower PO2 in the control group. Sodium bicarbonate did not worsen outcome, as measured by mortality and postmortem pathologic evaluation, and appeared to improve arterial blood gas values (Chisholm et al, 1989).
    F) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Eye Exposure

    6.8.1) DECONTAMINATION
    A) Sodium hypochlorite 5.25% solutions (household bleach) have a pH of 10.8 to 11.4 and may cause alkaline burns when splashed into the eye. If irrigated promptly, ocular injury is usually limited to mild corneal epithelial erosion and faint corneal haziness, which resolves within 48 hours (Ingram, 1990).
    1) More serious injury, with corneal edema and conjunctival hemorrhage, may occur if irrigation is delayed (Grant, 1986).
    B) HOME DECONTAMINATION
    1) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).
    C) MEDICAL FACILITY DECONTAMINATION
    1) If in a medical facility, sterile saline should be used to irrigate the eyes until the cul de sac is returned to neutrality. A slit lamp examination should be considered following thorough irrigation. Prolonged irrigation may be required. Application of an ophthalmic local anesthetic will increase patient comfort and facilitate eye irrigation.
    2) Determine the pH of the conjunctival sac at the completion of irrigation. Irrigation should be continued if the pH is not neutral.
    6.8.2) TREATMENT
    A) IRRIGATION
    1) Begin irrigation immediately with copious amounts of water or sterile 0.9% saline, which ever is more rapidly available. Lactated Ringer's solution may also be effective. Once irrigation has begun, instill a drop of local anesthetic (eg, 0.5% proparacaine) for comfort; switching from water to slightly warmed sterile saline may also improve patient comfort (Singh et al, 2013; Spector & Fernandez, 2008; Ernst et al, 1998; Grant & Schuman, 1993). In one study, isotonic saline, lactated Ringer's solution, normal saline with bicarbonate, and balanced saline plus (BSS Plus) were compared and no difference in normalization of pH were found; however, BSS Plus was better tolerated and more comfortable (Fish & Davidson, 2010).
    a) Continue irrigation for at least an hour or until the superior and inferior cul-de-sacs have returned to neutrality (check pH every 30 minutes), pH of 7.0 to 8.0, and remain so for 30 minutes after irrigation is discontinued (Spector & Fernandez, 2008; Brodovsky et al, 2000a). After severe alkaline burns, the pH of the conjunctival sac may only return to a pH of 8 or 8.5 even after extensive irrigation (Grant & Schuman, 1993). Irrigating volumes up to 20 L or more have been used to neutralize the pH (Singh et al, 2013; Fish & Davidson, 2010). Immediate and prolonged irrigation is associated with improved visual acuity, shorter hospital stay and fewer surgical interventions (Kuckelkorn et al, 1995; Saari et al, 1984).
    b) Search the conjunctival sac for solid particles and remove them while continuing irrigation (Grant & Schuman, 1993).
    c) For significant alkaline or concentrated acid burns with evidence of eye injury irrigation should be continued for at least 2 to 3 hours, potentially as long as 24 to 48 hours if pH not normalized, in an attempt to normalize the pH of the anterior chamber (Smilkstein & Fraunfelder, 2002). Emergent ophthalmologic consultation is needed in these cases (Spector & Fernandez, 2008).
    B) OBSERVATION REGIMES
    1) ASSESSMENT CAUSTIC EYE BURNS: It may take 48 to 72 hours after the burn to assess correctly the degree of ocular damage (Brodovsky et al, 2000).
    2) The 1965 Roper-Hall classification uses the size of the corneal epithelial defect, the degree of corneal opacification and extent of limbal ischemia to evaluate the extent of the chemical ocular injury (Brodovsky et al, 2000; Singh et al, 2013):
    a) GRADE 1 (prognosis good): Corneal epithelial damage; no limbal ischemia.
    b) GRADE 2 (prognosis good): Cornea hazy; iris details visible, ischemia less than one-third of limbus.
    c) GRADE 3 (prognosis guarded): Total loss of corneal epithelium; stromal haze obscures iris details; ischemia of one-third to one-half of limbus.
    d) GRADE 4 (prognosis poor): Cornea opaque; iris and pupil obscured, ischemia affects more than one-half of limbus.
    3) A newer classification (Dua) is based on clock hour limbal involvement as well as a percentage of bulbar conjunctival involvement (Singh et al, 2013):
    a) GRADE 1 (prognosis very good): 0 clock hour of limbal involvement and 0% conjunctival involvement.
    b) GRADE 2 (prognosis good): Less than 3 clock hour of limbal involvement and less than 30% conjunctival involvement.
    c) GRADE 3 (prognosis good): Greater than 3 and up to 6 clock hour of limbal involvement and greater than 30% to 50% conjunctival involvement.
    d) GRADE 4 (prognosis good to guarded): Greater than 6 and up to 9 clock hour of limbal involvement and greater than 50% to 75% conjunctival involvement.
    e) GRADE 5 (prognosis guarded to poor): Greater than 9 and less than 12 clock hour of limbal involvement and greater than 75% and less than 100% conjunctival involvement.
    f) GRADE 6 (very poor): Total limbus (12 clock hour) involved and 100% conjunctival involvement.
    C) SUPPORT
    1) SUMMARY
    a) If ocular damage is minor, artificial tears/lubricants, topical cycloplegics, and antibiotics may be all that are needed.
    2) ARTIFICIAL TEARS
    a) To promote re-epithelization, preservative-free artificial tears/lubricants (eg, hyaluronic acid hourly) may be used (Fish & Davidson, 2010; Tuft & Shortt, 2009).
    3) TOPICAL CYCLOPLEGIC
    a) Use to guard against development of posterior synechiae and ciliary spasm (Brodovsky et al, 2000b; Grant & Schuman, 1993). Cyclopentolate 0.5% or 1% eye drops may be administered 4 times daily to control pain (Tuft & Shortt, 2009; Spector & Fernandez, 2008).
    4) TOPICAL ANTIBIOTICS
    a) An antibiotic ophthalmic ointment or drops should be used for as long as epithelial defects persist (Brodovsky et al, 2000b; Grant & Schuman, 1993). Topical erythromycin or tetracycline ointment may be used (Spector & Fernandez, 2008).
    5) PAIN CONTROL
    a) If pain control is required, oral or parenteral NSAIDs or narcotics are preferred to topical ocular anesthetics, which may cause local corneal epithelial damage if used repeatedly (Spector & Fernandez, 2008; Grant & Schuman, 1993). However, topical 0.5% proparacaine has been recommended (Spector & Fernandez, 2008).
    6) SUMMARY
    a) If the damage is minor, the above may be all that is needed. For grade 3 or 4 injuries, one or more of the following may be used, only with ophthalmologic consultation: acetazolamide, topical timolol, topical steroids, citrate, ascorbate, EDTA, cysteine, NAC, penicillamine, tetracycline, or soft contact lenses.
    7) ARTIFICIAL TEARS
    a) To promote re-epithelization, preservative-free artificial tears/lubricants (eg, hyaluronic acid hourly) may be used (Fish & Davidson, 2010; Tuft & Shortt, 2009).
    8) PAIN CONTROL
    a) If pain control is required, oral or parenteral NSAIDs or narcotics are preferred to topical ocular anesthetics, which may cause local corneal epithelial damage if used repeatedly (Spector & Fernandez, 2008; Grant & Schuman, 1993). However, topical 0.5% proparacaine has been recommended (Spector & Fernandez, 2008).
    9) CARBONIC ANHYDRASE INHIBITOR
    a) Acetazolamide (250 mg orally 4 times daily) may be given to control increased intraocular pressure (Singh et al, 2013; Tuft & Shortt, 2009; Spector & Fernandez, 2008).
    10) TOPICAL STEROIDS
    a) DOSE: Dexamethasone 0.1% ointment 4 times daily to reduce inflammation. If persistent epithelial defect is present, discontinue dexamethasone by day 14 to reduce the risk of stromal melt (Tuft & Shortt, 2009). Other sources suggest that corticosteroids should be stopped if the epithelium has not covered surface defects by 5 to 7 days (Grant & Schuman, 1993a).
    b) Topical prednisolone 0.5% has also been used. A further increase in corneoscleral melt may occur if topical steroids are used alone. In one study, topical prednisolone 0.5% was used in combination with topical ascorbate 10%; no increase in corneoscleral melt was observed when topical steroids were used until re-epithelization (Singh et al, 2013; Fish & Davidson, 2010).
    c) In one retrospective study, fluorometholone 1% drops were administered every 2 hours initially, then decreased to four times daily when there was evidence of progressive corneal reepithelialization and lessened inflammation, and discontinued when corneal reepithelialization was complete (Brodovsky et al, 2000a).
    1) STUDY: The combination of intensive topical corticosteroids, topical citrate and ascorbate, and oral citrate and ascorbate was associated with improved best corrected visual acuity and a trend towards more rapid corneal reepithelialization in Grade 3 alkali burns in one retrospective study (Brodovsky et al, 2000a).
    11) ASCORBATE
    a) Oral or topical ascorbate may be used to promote epithelial healing and reduce the risk of stromal necrosis (Fish & Davidson, 2010).
    b) DOSE: Ascorbate 10% 4 times daily topically or 1 g orally (2 g/day) (Singh et al, 2013; Tuft & Shortt, 2009).
    c) Ascorbate is needed for the formation of collagen and the concentration of ascorbate in the anterior chamber is decreased when the ciliary body is damaged by alkali burns (Tuft & Shortt, 2009; Grant & Schuman, 1993a). In one retrospective study, ascorbate drops (10%) were administered every 2 hours, then decreased to 4 times a day when there was evidence of progressive corneal reepithelialization and lessened inflammation, and discontinued when corneal reepithelialization was complete. These patients also received 500 mg of oral ascorbate 4 times daily, until discharge from the hospital (Brodovsky et al, 2000a).
    1) STUDY: The combination of intensive topical corticosteroids, topical citrate and ascorbate, and oral citrate and ascorbate was associated with improved best corrected visual acuity and a trend towards more rapid corneal reepithelialization in Grade 3 alkali burns in one retrospective study (Brodovsky et al, 2000a).
    12) CITRATE
    a) Topical citrate may be used to promote epithelial healing and reduce the risk of stromal necrosis (Fish & Davidson, 2010).
    b) DOSE: Potassium citrate 10% 4 times daily topically (Tuft & Shortt, 2009).
    c) Citrate chelates calcium, and thereby interferes with the harmful effects of neutrophil accumulation, such as release of proteolytic enzymes and superoxide free radicals, phagocytosis and ulceration (Grant & Schuman, 1993a). In one retrospective study, 10% citrate drops were administered every 2 hours, then decreased to 4 times a day when there was evidence of progressive corneal reepithelialization and lessened inflammation, and discontinued when corneal reepithelialization was complete. These patients also received a urinary alkalinizer containing 720 mg of citric acid anhydrous and 630 mg of sodium citrate anhydrous 3 times daily, until discharge from the hospital (Brodovsky et al, 2000a).
    1) STUDY: The combination of intensive topical corticosteroids, topical citrate and ascorbate, and oral citrate and ascorbate was associated with improved best corrected visual acuity and a trend towards more rapid corneal reepithelialization in Grade 3 alkali burns in one retrospective study (Brodovsky et al, 2000a).
    13) COLLAGENASE INHIBITORS
    a) Inhibitors of collagenase can inhibit collagenolytic activity, prevent stromal ulceration, and promote wound healing. Several effective agents, such as cysteine, n-acetylcysteine, sodium ethylenediamine tetra acetic acid (EDTA), calcium EDTA, penicillamine, and citrate, have been recommended (Singh et al, 2013; Tuft & Shortt, 2009; Perry et al, 1993; Seedor et al, 1987).
    b) TETRACYCLINE: Has been found to have an anticollagenolytic effect. Systemic tetracycline 50 mg/kg/day reduced the incidence of alkali-induced corneal ulcerations in rabbits (Seedor et al, 1987).
    c) DOXYCYCLINE: Decreased epithelial defects and collagenase activity in a rabbit model of alkali burns to the eye (Perry et al, 1993). DOSE: 100 mg twice daily (Tuft & Shortt, 2009).
    14) ANTIBIOTICS
    a) An antibiotic ophthalmic ointment or drops should be used for as long as epithelial defects persist (Brodovsky et al, 2000b; Grant & Schuman, 1993). Topical erythromycin or tetracycline ointment may be used (Spector & Fernandez, 2008). In patients with severe burns, a topical fluoroquinolone antibiotic drop 4 times daily may also be used (Tuft & Shortt, 2009). A topical fourth generation fluoroquinolone has been recommended as an antimicrobial prophylaxis in patients with large epithelial defect (Fish & Davidson, 2010).
    15) TOPICAL CYCLOPLEGIC
    a) Cyclopentolate 0.5% or 1% eye drops may be administered 4 times daily to control pain (Tuft & Shortt, 2009; Spector & Fernandez, 2008).
    16) SOFT CONTACT LENSES
    a) A bandage contact lens (eg, silicone hydrogel) may make the patient more comfortable and protect the surface (Fish & Davidson, 2010; Tuft & Shortt, 2009). Hydrophilic high oxygen permeability lenses are preferred (Singh et al, 2013). Soft lenses with intermediate water content and inherent rigidity may facilitate reepithelialization. The use of 0.5 normal sodium chloride drops hourly and artificial tears or lubricant eyedrops instilled 4 times a day may help maintain adequate hydration and lens mobility.
    17) SURGICAL THERAPY CAUSTIC EYE INJURY
    a) Early insertion of methylmethacrylate ring or suturing saran wrap over palpebral and cul-de-sac conjunctiva may prevent fibrinosis adhesions and reduce fibrotic contracture of conjunctiva, but the advantage of such treatments is not clear.
    b) Limbal stem cell transplantation has been used successfully in both the acute stage of injury and the chronically scarred healing phase in patients with persistent epithelial defects after chemical burns (Azuara-Blanco et al, 1999; Morgan & Murray, 1996; Ronk et al, 1994).
    c) In some patients, amniotic membrane transplantation (AMT) has been successful in improving corneal healing and visual acuity in patients with persistent epithelial defects after chemical burns. It can restore the conjunctival surface and decrease limbal stromal inflammation (Fish & Davidson, 2010; Sridhar et al, 2000; Su & Lin, 2000; Meller et al, 2000; Azuara-Blanco et al, 1999).
    d) Control glaucoma. Remove any cataracts formed (Fish & Davidson, 2010; Tuft & Shortt, 2009).
    e) In patients with severe injury, tenonplasty can be performed to promote epithelialization and prevent melting (Tuft & Shortt, 2009).
    f) A keratoprosthesis placement has also been indicated in severe cases (Fish & Davidson, 2010). Penetrating keratoplasty is usually delayed as long as possible as results appear to be better with a greater lag time between injury and keratoplasty (Grant & Schuman, 1993).
    D) Treatment should include recommendations listed in the ORAL EXPOSURE section when appropriate.

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DERMAL DECONTAMINATION
    1) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).
    2) Remove contaminated clothing. Wash all exposed clothes with soap and water.

Case Reports

    A) ADULT
    1) ROUTE OF EXPOSURE
    a) ORAL
    1) A 66-year-old woman who ingested 500 mL of sodium hypochlorite 10% bleach was treated with gastric lavage with sodium thiosulfate 2 hours postingestion. Laboratory values at the time showed metabolic acidosis and a serum sodium of 150 mmol/L. Eight hours after admission, the patient's serum sodium was 169 mmol/L and chloride 130 mmol/L. Electrolytes improved over 24 hours.
    a) Five days later, the patient was discharged with esophagitis and dysphagia. The hyperchloremic acidosis was postulated to be due to conversion of hypochlorite to hypochlorous acid and chlorine after reacting with hydrochloric acid in the stomach. The sodium load from the ingested bleach (673 mmol) was sufficient to account for the hypernatremia (Ward & Routledge, 1988).

Summary

    A) TOXICITY: Significant caustic injury from household products is rare and is only likely to develop after large, deliberate ingestions by adults. Respiratory injury from evolved chlorine or chloramine gas is more likely to develop in closed spaces. A woman developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. She recovered following supportive care.

Minimum Lethal Exposure

    A) CASE REPORTS
    1) A 1-year-old child died after swallowing a large amount of a household cleanser containing 4.5% sodium hypochlorite in an alkaline (pH 12.0) solution. Postmortem revealed severe mucosal necrosis of the esophagus and stomach; the face, mouth, tongue, glottis, epiglottis, esophagus, and stomach were reddish-black and swollen (Jakobsson et al, 1991).
    B) ANIMAL DATA
    1) Rats given 5 to 15 mL/kg of an alkaline (pH 12.0) solution containing 4.5% sodium hypochlorite died within 1 to 3 hours. Severe local damage to the esophagus and stomach were noted (Jakobsson et al, 1991).

Maximum Tolerated Exposure

    A) GENERAL/SUMMARY
    1) Since this is an ingestion usually seen in toddlers who have spilled as much or more than they have ingested, it is impossible to estimate the toxic dose. Reported cases with complications have ingested a few ounces or more of household concentrate.
    2) Ingestion of 500 mL of 10% sodium hypochlorite resulted in superficial mouth burns, esophagitis, dysphagia, and severe metabolic disturbance, with survival in a 66-year-old woman (Ward & Routledge, 1988).
    3) Ingestion of large quantities of household bleach (greater than 5 mL/kg) may be associated with corrosive damage (Jakobsson et al, 1991).
    B) INHALATION
    1) Twenty-four persons became ill (eg, burning eyes, sore throat, watery eyes, coughing, sneezing, burning inside the nose, wheezing, chest tightness, dyspnea, headache, blurry eyes, dry mouth, nausea, diarrhea, vomiting, abdominal cramping, rash, fever, photophobia) after exposure to toxic levels of chloramines from an indoor motel swimming pool. Inspection of the pool showed several state health code violations, including cloudy water, a free chlorine level (0.8 parts per million [ppm]) less than half the minimum, a chloramine level (4.2 ppm) 8 times the maximum, and a pH (3.95) approximately half the minimum (Center for Disease Control and Prevention, 2007).
    C) INJECTION
    1) An 18-year-old woman developed acute renal injury, intravascular hemolysis, and mild myocardial injury after injecting herself with 100 mL of Clorox(R) Lemon Fresh Bleach (1% to 5% sodium hypochlorite and 0.1% to 1% sodium hydroxide) through a tunneled catheter. Following supportive care, her hemolysis and myocardial injury resolved over the next 96 hours; however, she continued to be anuric and azotemic. Her renal function gradually recovered after 7 hemodialysis sessions (Verma et al, 2013).

Toxicologic Mechanism

    A) Sodium hypochlorite is toxic when in contact with mucous membranes, as acidic solutions produce hypochlorous acid, an irritant that may be a corrosive.
    B) Note the following chemical interactions :
       1. Sodium hypochlorite and mucous membrane of the
          mouth, esophagus and stomach
             2NaCLO + H2O + CO2 -----Na2CO3 + 2HCLO
             2HCLO -----2HCl + O2
       2. Acid Toilet Bowl Cleaners - produce chlorine
          gas which may result in burning of mucous
          membranes and chemical pneumonitis.
             NaOCl + HCl + H2O ----- Cl2 + 2 NaOH
       3. Ammonia - produces chloramine which may result
          in irritation, burning and pneumonitis.
          Chloramine then hydrolyzes in the distal
          airways and alveoli to ammonia and
          hypochlorous acid, resulting in pneumonitis.
             NH3 + NaOCl ----- NH2Cl + Na + OH
       4. Detergents (those not containing ammonia) -
          produce no toxic gas.
       5. Sodium Hydroxide - produces no toxic gas.
    

    C) The toxic effects resulting from exposure to alkaline sodium hypochlorite solutions are primarily related to the oxidizing capacity of the hypochlorite ion and the pH of the solution (Jakobsson et al, 1991).

Physical Characteristics

    A) SODIUM HYPOCHLORITE is a white, crystalline solid (ITI, 1985). The aqueous solution is a green to yellowish watery liquid with the odor of liquid bleach (CHRIS , 1985).
    B) CALCIUM HYPOCHLORITE is a white crystalline or granular solid with the odor of bleach (CHRIS , 1985; ITI, 1985).

Molecular Weight

    A) 74.44 (Sodium Hypochlorite) (Windholz et al, 1983)
    B) 142.99 (Calcium Hypochlorite) (Windholz et al, 1983)

Clinical Effects

    11.1.13) OTHER
    A) OTHER
    1) Clinical signs may include salivation, emesis, abdominal pain and tenderness, hematemesis, and bleached hair (Coppock et al, 1988).

Treatment

    11.2.4) DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) Emesis is likely to be spontaneous. Induced emesis is not recommended. Demulcents such as milk of magnesia (0.2 to 0.3 mL/kg) egg white, corn starch, or powdered milk slurry may be beneficial (Coppock et al, 1988).

Continuing Care

    11.4.2) DECONTAMINATION
    11.4.2.2) GASTRIC DECONTAMINATION
    A) GASTRIC DECONTAMINATION
    1) GENERAL TREATMENT
    a) Emesis is likely to be spontaneous. Induced emesis is not recommended. Demulcents such as milk of magnesia (0.2 to 0.3 mL/kg) egg white, corn starch, or powdered milk slurry may be beneficial (Coppock et al, 1988).

General Bibliography

    1) Artigas A, Bernard GR, Carlet J, et al: The American-European consensus conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling.. Am J Respir Crit Care Med 1998; 157:1332-1347.
    2) Aslan S, Kandis H, Akgun M, et al: The effect of nebulized NaHCO3 treatment on "RADS" due to chlorine gas inhalation. Inhal Toxicol 2006; 18(11):895-900.
    3) Azuara-Blanco A, Pillai CT, & Dua HS: Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999; 83:399-402.
    4) Babl FE, Kharsch S, & Woolf A: Airway edema following household bleach ingestion. Am J Emerg Med 1998; 16:514-516.
    5) Becker GL, Cohen S, & Borer R: The sequelae of accidentally injecting sodium hypochlorite beyond the root apex. Oral Surg 1974; 38:633-638.
    6) Becking AG: Complications in the use of sodium hypochlorite during endodontic treatment. Oral Surg Oral Med Oral Pathol 1991; 71:346-348.
    7) Bosse GM: Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol 1994; 32(3):233-241.
    8) Bracco D, Dubois MJ, & Bouali R: Intoxication by bleach ingestion (letter). Can J Anesth 2005; 52:118-119.
    9) Brodovsky SC, McCarty AC, & Snibson G: Management of alkali burns an 11-year retrospective review. Ophthalmology 2000; 107:1829-1835.
    10) Brodovsky SC, McCarty CA, & Snibson G: Management of alkali burns an 11-year retrospective review. Ophthalmology 2000a; 107:1829-1835.
    11) Brodovsky SC, McCarty CA, & Snibson G: Management of alkali burns an 11-year review. Ophthalmology 2000b; 107:1829-1835.
    12) Brower RG, Matthay AM, & Morris A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Eng J Med 2000; 342:1301-1308.
    13) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    14) CHRIS : CHRIS Hazardous Chemical Data. US Department of Transportation, US Coast Guard. Washington, DC (Internet Version). Edition expires 1985; provided by Truven Health Analytics Inc., Greenwood Village, CO.
    15) Caravati EM: Alkali. In: Dart RC, ed. Medical Toxicology, Lippincott Williams & Wilkins, Philadelphia, PA, 2004.
    16) Cataletto M: Respiratory Distress Syndrome, Acute(ARDS). In: Domino FJ, ed. The 5-Minute Clinical Consult 2012, 20th ed. Lippincott Williams & Wilkins, Philadelphia, PA, 2012.
    17) Center for Disease Control and Prevention: Ocular and respiratory illness associated with an indoor swimming pool--Nebraska, 2006. MMWR Morb Mortal Wkly Rep 2007; 56(36):929-932.
    18) Centers for Disease Control and Prevention: Multistate outbreak of listeriosis associated with Jensen Farms cantaloupe--United States, August-September 2011. MMWR Morb Mortal Wkly Rep 2011; 60(39):1357-1358.
    19) Cevik Y, Onay M, Akmaz I, et al: Mass casualties from acute inhalation of chlorine gas. South Med J 2009; 102(12):1209-1213.
    20) Chisholm CD, Singletary EM, & Okerberg CV: Inhaled sodium bicarbonate therapy for chlorine inhalation injuries (Abstract). Ann Emerg Med 1989; 18:466.
    21) Cohn P, Navitski M, & Monaco A: Permanganate as a cause of apparent chloramine breakthrough in dialysis water. Semin Dial 2005; 18:351-352.
    22) Davis MK, Barrett SE, & McGuire MJ: The change of water treatment methods from chlorine to chloramine by water districts. Contemporary Dialysis 1984; 5:31-33.
    23) De Gennaro L, Brunetti ND, Buquicchio F, et al: Takotsubo cardiomyopathy induced by acute inhalation of hypochlorite drain gel exhalations. Int J Cardiol 2015; 180:216-217.
    24) De Torres JP, Strom JA, Jaber BL, et al: Hemodialysis-associated methemoglobinemia in acute renal failure. Am J Kidney Diseases 2002; 39(6):1307-1309.
    25) Done AK: The toxic emergency: it's a gas. Emerg Med 1976; 305-314.
    26) Douidar SM: Nebulized sodium bicarbonate in acute chlorine inhalation. Pediatric Emerg Care 1997; 13:406-407.
    27) Eaton JW, Kolpin CF, & Swafford HS: Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science 1973; 181:463-464.
    28) Ernst AA, Thomson T, & Haynes ML: Warmed versus room temperature saline solution for ocular irrigation: a randomized clinical trial. Ann Emerg Med 1998; 32:676-679.
    29) Fish R & Davidson RS: Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol 2010; 21(4):317-321.
    30) Fisher AA: Dermatitis from chlorine and certain chlorinated products. Cutis 1984; 33:20-24.
    31) French RJ, Tabb HJ, & Rutledge LJ: Esophageal stenosis produced by ingestion of bleach. South Med J 1970; 63:1140.
    32) Gapany-Gapanavicius M, Molho M, & Tirosh M: Chloramine-induced pneumonitis from mixing household cleaning agents. Br Med J 1982; 285:1086.
    33) Gapany-Gapanavicius M, Molho M, & Tirosh M: Chloramine-induced pneumonitis from mixing household cleaning agents. Br Med J 1982a; 285:1686.
    34) Gapany-Gapanavicius M, Yellin A, & Almong S: Pneumomediastinum - a complication of chlorine exposure from mixing household cleaning agents. JAMA 1982b; 248:345-350.
    35) Gosselin RE, Smith RP, & Hodge HC: Clinical Toxicology of Commercial Products, 5th Ed, Williams and Wilkins, Baltimore, MD, 1984.
    36) Gosselin RE, Smith RP, Hodge HC, et al: Clinical Toxicology of Commercial Products, 5th. Williams & Wilkins, Baltimore, 1984a.
    37) Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993.
    38) Grant WM & Schuman JS: Toxicology of the Eye, 4th ed, Charles C Thomas, Springfield, IL, 1993a.
    39) Grant WM: Toxicology of the Eye, 3rd ed, Charles C. Thomas, Springfield, IL, 1986.
    40) Guloglu C, Kara IH, & Erten PG: Acute accidental exposure to chlorine gas in the Southeast of Turkey: a study of 106 cases. Environ Res 2002; 88:89-93.
    41) Haag JR & Gieser RG: Effects of swimming pool water on the cornea. JAMA 1983; 249:2507-2508.
    42) Haas CF: Mechanical ventilation with lung protective strategies: what works?. Crit Care Clin 2011; 27(3):469-486.
    43) Heidemann SM & Goetting MG: Treatment of acute hypoxemic respiratory failure caused by chlorine exposure. Pediatr Emerg Care 1991; 7:87-88.
    44) Hilbert G & Bedry R: Hypernatraemia: an unusual cause of death after a caustic ingestion (abstract), EAPCCT XVI International Congress, Vienna, Austria, 1994.
    45) Hilbert G, Bedry R, & Cardinaud JP: Euro bleach: fatal hypernatremia due to 13.3% sodium hypochlorite (letter). Clin Toxicol 1997; 35:635-636.
    46) Hoy RH: Accidental systemic exposure to sodium hypochlorite (Clorox) during hemodialysis. Am J Hosp Pharm 1981; 38:1512-1513.
    47) ITI: Toxic and Hazardous Industrial Chemicals Safety Manual, The International Technical Information Institute, Tokyo, Japan, 1985, pp 102-103-482-483.
    48) Ingram TA: Response of the human eye to accidental exposure to sodium hypochlorite. J Endodontics 1990; 16:235-238.
    49) Jakobsson SW, Rajs J, & Jonsson JA: Poisoning with sodium hypochlorite solution. Report of a fatal case, supplemented with an experimental and clinico-epidemiological study. POLTOX Abstract Number: TOXBIB-92-221994. Am J Forensic Med Pathol 1991a; 12(4):320-327.
    50) Jakobsson SW, Rajs J, & Jonsson JA: Poisoning with sodium hypochlorite solution; report of a fatal case, supplemented with an experimental and clinico-epidemiological study. Am J Forensic Med Pathol 1991; 12:320-327.
    51) Kiristioglu I, Gurpinar A, & Kilic N: Is it necessary to perform an endoscopy after the ingestion of liquid household bleach in children?. Act Paediatr 1999; 88:233-234.
    52) Kjellstrand CM, Eaton JM, & Yawata Y: Hemolysis in dialyzed patients caused by chloramines. Nephron 1974; 13:427-433.
    53) Klein E: The use of granular activated charcoal in reducing chloramine concentration in water. Contemporary Dialysis 1984; 5:33-41.
    54) Kollef MH & Schuster DP: The acute respiratory distress syndrome. N Engl J Med 1995; 332:27-37.
    55) Kuckelkorn R, Kottek A, & Schrage N: Poor prognosis of severe chemical and thermal eye burns: the need for adequate emergency care and primary prevention. Int Arch Occup Environ Health 1995; 281-284.
    56) Landau GD & Saunders WH: The effect of chlorine bleach on the esophagus. Arch Otolaryngol 1964; 80:174-176.
    57) MMWR: Chlorine gas toxicity from mixture of bleach with other cleaning products - California. MMWR 1991; 40(36):619-629.
    58) Mehra P, Clancy C, & Wu J: Formation of a facial hematoma during endodontic therapy. JADA 2000; 131:67-71.
    59) Meller D, Pires RT, & Mack RJS: Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 2000; 107:980-990.
    60) Minami M, Katsumata M, & Miyake K: Dangerous mixture of household detergents in an old-style toilet: a case report with simulation experiments of the working environment and warning of potential hazard relevant to the general environment. Hum Exp Toxicol 1992; 11:27-34.
    61) Morgan DL: Intravenous injection of household bleach. Ann Emerg Med 1992; 21:1394-1395.
    62) Morgan S & Murray A: Limbal autotransplantation in the acute and chronic phases of severe chemical injuries. Eye 1996; 10:349-354.
    63) Mrvos R, Dean BS, & Krenzelok EP: Home exposures to chlorine/chloramine gas: review of 216 cases. South Med J 1993; 86:654-657.
    64) NHLBI ARDS Network: Mechanical ventilation protocol summary. Massachusetts General Hospital. Boston, MA. 2008. Available from URL: http://www.ardsnet.org/system/files/6mlcardsmall_2008update_final_JULY2008.pdf. As accessed 2013-08-07.
    65) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    66) National Asthma Education and Prevention Program: Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120(5 Suppl):S94-S138.
    67) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    68) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    69) Perry HD, Hodes LW, & Seedor JA: Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model. Preliminary observations. Cornea 1993; 12:379-82.
    70) Phillip R, Shepard C, & Fawthrop F: Domestic chlorine poisoning. Lancet 1985; 2:495.
    71) Pike DG, Peabody JW, & David EW: A re-evaluation of the dangers of clorox ingestion. J Pediatr 1963; 63:303-305.
    72) Racioppi F, Daskaleros PA, & Besbelli N: The human safety of household bleaches based on sodium hypochlorite solutions in the experience of poison control centers (abstract), EAPCCT XVI International Congress, Vienna, Austria, 1994.
    73) Racioppi F, Daskaleros PA, Besbelli N, et al: Household bleaches based on sodium hypochlorite: review of acute toxicology and poison control center experience. Food Chem Toxicol 1994a; 32(9):845-861.
    74) Reisz GR & Gammon RS: Toxic pneumonitis from mixing household cleaners. Chest 1986; 89:49-52.
    75) Ronk JF, Ruiz-Esmenjaud S, & Osorio M: Limbal conjunctival autograft in subacute alkaline corneal burn. Cornea 1994; 13:465-468.
    76) Rotman HH, Fliegelmann MJ, & Moore T: Effects of low concentrations of chlorine on pulmonary functions in humans. J Appl Physiol: Resp Environ Exercise Physiol 1983; 54(4):1120-1124.
    77) Saari KM, Leinonen J, & Aine E: Management of chemical eye injuries with prolonged irrigation. Acta Ophthalmol Suppl 1984; 52-59.
    78) Sastre J, Madero MF, Fernandez-Nieto M, et al: Airway response to chlorine inhalation (bleach) among cleaning workers with and without bronchial hyperresponsiveness. Am J Ind Med 2011; 54(4):293-299.
    79) Sax NI: Dangerous Properties of Industrial Materials, 6th ed, Van Nostrand Reinhold Company, New York, NY, 1984, pp 1603-2435-2436.
    80) Seedor JA, Perry HD, & McNamara TF: Systemic tetracycline treatment of alkali-induced corneal ulceration in rabbits. Arch Ophthalmol 1987; 105:268-271.
    81) Singh P, Tyagi M, Kumar Y, et al: Ocular chemical injuries and their management. Oman J Ophthalmol 2013; 6(2):83-86.
    82) Siodlak MZ, Gleeson MJ, & Wengraft CI: Accidental ingestion of sterilizing tablets by children. Br Med J Clin Research Ed 1985; 290:1707-1985.
    83) Smilkstein MJ & Fraunfelder F: Ophthalmic Principles, In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies. 7th ed., McGraw-Hill, New York, NY, 2002.
    84) Spector J & Fernandez WG: Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am 2008; 26(1):125-136.
    85) Spiller HA, Ross MP, & Nichols GR: Fatal caustic ingestion of sodium hypochlorite bleach with associated hypernatremic-hyperchloremic acidosis (abstract). Vet Hum Toxicol 1994; 36.
    86) Sridhar MS, Bansal AK, & Sangwan VS: Amniotic membrans transplantation in acute chemical and thermal injury. Am J Ophthalmol 2000; 130:134-137.
    87) Stolbach A & Hoffman RS: Respiratory Principles. In: Nelson LS, Hoffman RS, Lewin NA, et al, eds. Goldfrank's Toxicologic Emergencies, 9th ed. McGraw Hill Medical, New York, NY, 2011.
    88) Strange DC, Finneran JC, & Shumacker HB: Corrosive injury of the stomach. Arch Surg 1951; 62:350-357.
    89) Su CY & Lin CP: Combined use of an amniotic membrane and tissue adhesive in treating corneal perforation: a case report. Ophtalmic Sufr Lasers 2000; 31:151-154.
    90) Tanen DA, Graeme KA, & Raschke R: Severe lung injury after exposure to chloramine gas from houshold cleaners (letter). New Eng J Med 1999; 341:848-849.
    91) Traub SJ, Hoffman RS, & Nelson LS: Case report and literature review of chlorine gas toxicity. Vet Human Toxicol 2002; 44(4):235-239.
    92) Tuckler V, Martinez J, Smith G, et al: Intentional intravenous injection of sodium hypochlorite. J Toxicol Clin Toxicol 2002; 40(5):687.
    93) Tuft SJ & Shortt AJ: Surgical rehabilitation following severe ocular burns. Eye (Lond) 2009; 23(10):1966-1971.
    94) Vajner JE & Lung D: Case files of the University of California San Francisco Medical Toxicology Fellowship: acute chlorine gas inhalation and the utility of nebulized sodium bicarbonate. J Med Toxicol 2013; 9(3):259-265.
    95) Van Rhee F & Beaumont DM: Gastric stricture complicating oral ingestion of bleach. Br J Clin Pract 1990; 44:681-682.
    96) Verma A, Vanguri VK, Golla V, et al: Acute kidney injury due to intravenous bleach injection. J Med Toxicol 2013; 9(1):71-74.
    97) Vinsel PS: Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate. J Emerg Med 1990; 8:327-329.
    98) Ward MJ & Routledge PA: Hypernatraemia and hyperchloraemic acidosis after bleach ingestion. Human Toxicol 1988; 7:37-38.
    99) Willson DF, Truwit JD, Conaway MR, et al: The adult calfactant in acute respiratory distress syndrome (CARDS) trial. Chest 2015; 148(2):356-364.
    100) Wilson DF, Thomas NJ, Markovitz BP, et al: Effect of exogenous surfactant (calfactant) in pediatric acute lung injury. A randomized controlled trial. JAMA 2005; 293:470-476.
    101) Windholz M, Budavari S, & Blumetti RF: The Merck Index, 10th ed, Merck & Co, Inc, Rahway, NJ, 1983, pp 212-1115.
    102) Witton R, Henthorn K, Ethunandan M, et al: Neurological complications following extrusion of sodium hypochlorite solution during root canal treatment. Int Endod J 2005; 38(11):843-848.
    103) Wood BR, Colombo JL, & Benson BE: Chlorine inhalation toxicity from vapors generated by swimming pool chlorinator tablet. Pediatrics 1987; 79(3):427-430.
    104) Yarington CT, Bales GA, & Frazer JP: A study of the management of caustic esophageal trauma. Ann Otol Rhin & Laryng 1964; 73:1130-1135.
    105) Yigit O, Soyuncu S, Eray O, et al: Inhalational and dermal injury due to explosion of calcium hypochlorite. Cutan Ocul Toxicol 2009; 28(1):37-40.